Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185458
Status:
COMPLETED
Last Update Posted:
2013-11-27
First Post:
2005-09-13
Brief Title:
Assessment of the Transfer of Using Levonorgestrel Intrauterine System LNG IUS as a Contraceptive to Using it as Part of Hormone Replacement Therapy HRT
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A 60-month Non-comparative Study on Bleeding Profiles With Levonorgestrel Intrauterine System in Transition From Reproductive Age Contraception to Menopause Age Endometrial Protection During Estrogen Replacement Therapy
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study has been designed to look at the transfer from using LNG IUS for contraception only in reproductive age to using it for endometrial protection in menopausal age The main area of interest in the study is the pattern of any vaginal bleeding that occurs
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer HealthCare AG Germany Bayer HealthCare AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 300400 | OTHER | Company Internal | None |